Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer.
Saved in:
| Title: | Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. |
|---|---|
| Authors: | Sharp AM; Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Lertphinyowong S; Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Yee SS; Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Paredes D; Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Gelfond J; Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Johnson-Pais TL; Department of Urology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Mays Cancer Center, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Leach RJ; Department of Urology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Mays Cancer Center, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Department of Cell Systems & Anatomy, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Liss M; Department of Urology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Mays Cancer Center, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; South Texas Veterans Health Care Service, San Antonio, TX, 78229, USA., Risinger AL; Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Mays Cancer Center, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Sullivan AC; Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Department of Neurology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, 78229, USA., Thompson IM; Department of Urology, University of Texas Health Science Center, San Antonio, TX, 78229, USA.; CHRISTUS Santa Rosa Hospital, San Antonio, TX, 78229, USA., Morilak DA; Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX, 78229, USA. morilak@uthscsa.edu.; Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, 78229, USA. morilak@uthscsa.edu.; Mays Cancer Center, University of Texas Health Science Center, San Antonio, TX, 78229, USA. morilak@uthscsa.edu.; South Texas Veterans Health Care Service, San Antonio, TX, 78229, USA. morilak@uthscsa.edu. |
| Source: | Psychopharmacology [Psychopharmacology (Berl)] 2019 Nov; Vol. 236 (11), pp. 3183-3195. Date of Electronic Publication: 2019 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-2072 |
|---|---|
| DOI: | 10.1007/s00213-019-05274-4 |
